Unit of Endocrinology, Department of Translational Medicine and Surgery - Universita' Cattolica del Sacro Cuore, Fondazione Policlinico "Gemelli", IRCCS, Rome, Italy.
Unit of Chemistry, Biochemistry and Clinical Molecular Biology - Università Cattolica Del Sacro Cuore, Fondazione Policlinico "Gemelli," IRCCS, Rome, Italy.
Expert Rev Endocrinol Metab. 2022 May;17(3):205-224. doi: 10.1080/17446651.2022.2069558. Epub 2022 Apr 29.
Acromegaly is a rare disorder characterized by the excessive secretion of growth hormone (GH), mostly caused by pituitary adenomas. While in full-blown cases the diagnosis is easy to establish, milder cases are more challenging. Additionally, establishing whether full cure after surgery is reached may be difficult.
In this article, we will review the challenges posed by the variability in measurements of GH and its main effector insulin-like growth factor I (IGF-I) due to both biological changes, co-morbidities, and assays variability.
Interpretation of GH and IGF-I assays is important in establishing an early diagnosis of acromegaly, in avoiding misdiagnosis, and in establishing if cure is achieved by surgery. Physicians should be familiar with the variables that affect measurements of these 2 hormones, and with the performance of the assays available in their practice.
肢端肥大症是一种罕见的疾病,其特征是生长激素(GH)分泌过多,主要由垂体腺瘤引起。虽然在典型病例中诊断很容易,但更轻微的病例则更具挑战性。此外,确定手术后是否完全治愈可能很困难。
在本文中,我们将回顾由于生物学变化、合并症和检测方法的变异性,导致 GH 和其主要效应物胰岛素样生长因子 I(IGF-I)的测量值存在差异所带来的挑战。
解读 GH 和 IGF-I 检测对于早期诊断肢端肥大症、避免误诊以及确定手术是否实现治愈非常重要。医生应该熟悉影响这两种激素检测的变量,以及他们实践中可用的检测方法的性能。